iiinova — where your digital self keeps evolving

Reposted by Mohamed Elghazaly

Jolly Lab @jollylab.bsky.social · 06/05/2026

We are incredibly excited to see our most recent story out @nature.com today:HIV triggers CD4-signaling to remodel nuclear pores and license infection!A heroic effort led by our very own @d-mesner.bsky.social & @mattvxwhelan.bsky.social! @blizardinstitute.bsky.social Link: tinyurl.com/HIVNup 1/11

42011

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 20/01/2026

🚨Job Alert🚨 Looking for a highly motivated postdoctoral researcher to join our multidisciplinary team of scientists. The postdoc will collaborate with world-class structural biologist Peijun Zhang to understand everything about HIV capsids and how they work via host interactions. Spread the word!

qmul-jobs.tal.net

Postdoctoral Research Associate (Molecular Biology of HIV Infection) - QMUL Jobs

ID: 8551. Title: Postdoctoral Research Associate (Molecular Biology of HIV Infection). Application Deadline:

11914

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 14/11/2025

Our first Virtual Virology at QMUL! Three great speakers from my lab @melghazaly.bsky.social on Vpx and immune activation, @immun0liver.bsky.social on SARS and ADP-ribosylation, and @ali-hashim.bsky.social on transforming natural products into broad spectrum anti-virals. Excited for the next VV!

2104

Mohamed Elghazaly @melghazaly.bsky.social · 06/10/2025

Excited to share that the Towers Lab have moved from UCL to the @blizardinstitute.bsky.social. As such, I’ll be continuing working on #virology and #epigenetic regulation of #immunity from the Blizard! I look forward to meet new colleagues and continue working on great science. Get in touch!

130

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 29/09/2025

New preprint from our lab, led by our postdocs Dara Annett and Kate Morling in collaboration with Selwood Lab! We developed a modified cyclosporine, BG147, which enhances lentivector gene therapy transduction, ex vivo in HSPC and in vivo in mouse photoreceptors, by degrading IFITM3. Check it out!

biorxiv.org

A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3

Intrinsic innate immune barriers have evolved to suppress viral infection and can reduce effective gene delivery in gene therapy. We have developed BG147, a novel cyclosporine A analogue, optimised vi...

0127

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 29/09/2025

Delighted to have won a Wellcome Discovery Award for 8 more years of transformative research. We will advance our knowledge of innate immune mechanisms using viruses and chemotherapeutics as tools. Thanks to everyone who contributed along the way.

0194

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 10/07/2025

We are delighted to be joining the Blizard Institute in Autumn. The Blizard Institute is an amazing place for discovery science and we're looking forward to more transformative research and collaborations. www.qmul.ac.uk/blizard/abou...

qmul.ac.uk

Blizard Institute welcomes world-leading team of virologists

2267

Reposted by Mohamed Elghazaly

RM @rsbmilne.bsky.social · 20/06/2025

Virtual Virology 2 July - Three Pirbright PIs. Do join us

132

Reposted by Mohamed Elghazaly

London Infection Network for/by ECRs (LINE) @londoninfectionecr.bsky.social · 09/06/2025

Our last (but not least) selected speaker for today is @immun0liver.bsky.social @ucl.ac.uk with a great talk on how ADP-ribosylation poses an important barrier to infection that viruses like SARS-CoV-2 have to overcome. #LINEsymposium2025

1106

Mohamed Elghazaly @melghazaly.bsky.social · 09/06/2025

Towers Lab attending @londoninfectionecr.bsky.social (LINE) annual symposium. Great talk lineups at the Francis Crick Institute, London. #LINE #ScienceIsCool.

093

Mohamed Elghazaly @melghazaly.bsky.social · 04/06/2025

What an absolute privilege it was to be invited to speak at #UKCellularMicrobiology @KingsCollegeLon! Having attended this conference for years as a Salmonella biologist, it was really special to come back this time as a Virologist. #AcademicLife #CellularMicrobiology #Research

141

Mohamed Elghazaly @melghazaly.bsky.social · 30/05/2025

I had the great honour of being invited to speak at the Cold Spring Harbor Retroviruses Meeting in New York last week! #CSHRetroviruses #Retrovirology #Research

130

Mohamed Elghazaly @melghazaly.bsky.social · 21/05/2025

So inspiring just listening to a keynote lecture at Cold Spring Harbor by David Baltimore, a Nobel Prize Winner at the age of 37, and the discoverer of reverse transcriptase that quite literally changed the world. #CSHLRetro

031

Reposted by Mohamed Elghazaly

RM @rsbmilne.bsky.social · 08/05/2025

Virtual Virology is back - our first ever phage session. Do join us...

22212

Reposted by Mohamed Elghazaly

London Infection Network for/by ECRs (LINE) @londoninfectionecr.bsky.social · 10/04/2025

Thanks to everybody who made it to our seminar yesterday (IRL and remotely)! It was great to hear about their exciting science from @oscart32.bsky.social and @melghazaly.bsky.social. See you very soon at our symposium or the next seminar!

032

Reposted by Mohamed Elghazaly

Marion Delphin @mariondelphin.bsky.social · 02/04/2025

Come next Wednesday at 5pm at #UCL to listen to @oscart32.bsky.social and @melghazaly.bsky.social share their science and have a drink with us after! The event is hybrid to cater for availability and capacity, so if you cannot make it in person, join us online!

022

Reposted by Mohamed Elghazaly

London Infection Network for/by ECRs (LINE) @londoninfectionecr.bsky.social · 11/03/2025

🚨INCOMING! Join us for our next LINE seminar (9th of April) at UCL. We are excited to host @oscart32.bsky.social and @melghazaly.bsky.social to hear about metagenomics in diagnostics and how host/pathogens battle it out! As always: Followed by a networking social! Register here: shorturl.at/kGmfh

054

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 14/02/2025

Happy to announce that our 2nd paper of 2025 is out! 🎊 This collaboration between our brilliant postdoc @lsnewton.bsky.social and @claragathmann.bsky.social, from Dave Selwood’s chemistry lab, designs and employs PROTACs to degrade CypA and inhibit HIV and HCV. www.nature.com/articles/s41...

nature.com

Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV - Nature Communications

Targeted protein degradation has so far been rarely applied as an antiviral strategy. Here, the authors report that macrocycle-based PROTACs targeting host protein cyclophilin A, exploited during vira...

1143

Reposted by Mohamed Elghazaly

Towers Lab @towerslab.bsky.social · 14/01/2025

First paper of 2025 is out now! 🎉 Our talented postdocs @katemorling.bsky.social and @melghazaly.bsky.social review latest advancements of how HIV capsid and accessory proteins Vpx/Vpr have evolved (or not) to regulate host innate immunity. www.microbiologyresearch.org/content/jour...

0357

Mohamed Elghazaly @melghazaly.bsky.social · 14/01/2025

Very proud to have collaborated with @katemorling.bsky.social on this review as my first contribution to the virology field. Looking forward to more exciting work with @towerslab.bsky.social!

080